首页> 外文期刊>Biosciences Biotechnology Research Asia >Serum Adenosine Deaminase: A Novel Biomarker Tool for the Diagnosis of Tuberculosis
【24h】

Serum Adenosine Deaminase: A Novel Biomarker Tool for the Diagnosis of Tuberculosis

机译:血清腺苷脱氨酶:结核病诊断的新型生物标志物工具。

获取原文
获取原文并翻译 | 示例
       

摘要

Tuberculosis is a major health issues worldwide. Every year more than 9 million new cases are reported worldwide with death rate of around 2 million each year. Rapid and accurate diagnosis of tuberculosis in population is most supportive in proper medication and early recovery. The golden standard method for diagnosis of tuberculosis in patient is formerly culture method which is time consuming and cumbersome. Various other techniques used in the diagnosis of tuberculosis have poor sensitivity and specificity however serum adenosine deaminase (ADA) has emerged as a potent biochemical marker that can be used as tool for the diagnosis of tuberculosis for rapid, easy and better result. Increased level of ADA in blood generally indicates the presence oftuberculosis. In the present study, the serum ADA level was examined in 75 healthy control and 75 tuberculosis patients with positive sputum smear for acid fast bacilli (AFB), having clinical symptoms were diagnosed for pulmonary tuberculosis and radiological impression for extra pulmonary tuberculosis. The selection of cases and control were based on the inclusion and exclusion criteria. Samples were collected at the outpatient department of National Tuberculosis Centre, Nepal after asking simple questionnaires. Modified Guisti and Galanti method was adopted for estimation of serum ADA from pooled and processed blood samples. There was significant difference (p<0.001) in mean rank of level of serum ADA among the TB cases to controls. The P-TB had thehighest mean rank (116.52) followed by EP-TB (99.48) and control had significantly less mean rank (40.16). At the cut-off point of 25 U/L; sensitivity, specificity, positive predictive value and negative predictive value were 90.7%, 100%, 90.66% and 100% respectively. It can be concluded from data that there were insignificant difference in mean rank among sex wise distribution with p=0.037 and sputum grading wise distribution with p = 0.142.
机译:结核病是世界范围内的主要健康问题。每年全世界报告超过900万的新病例,每年的死亡率约为200万。对人群的结核病进行快速,准确的诊断对正确的药物治疗和早期康复最有帮助。诊断患者结核病的黄金标准方法是以前的培养方法,该方法既费时又麻烦。用于诊断结核病的各种其他技术的敏感性和特异性均较差,但是血清腺苷脱氨酶(ADA)已作为一种强大的生化标志物出现,可以用作诊断结核病的工具,以快速,简便和获得更好的结果。血液中ADA水平的升高通常表明存在结核病。在本研究中,对75例健康对照和75例痰涂片阳性的耐酸杆菌(AFB)进行了血清ADA检测,这些患者的临床症状被诊断为肺结核,影像学表现为肺结核。病例和对照的选择基于纳入和排除标准。在询问简单的问卷后,在尼泊尔国家结核病中心的门诊部收集了样本。采用改进的Guisti和Galanti方法从合并和处理后的血液样本中评估血清ADA。与对照组相比,结核病患者血清ADA水平的平均等级存在显着差异(p <0.001)。 P-TB的平均等级最高(116.52),其次是EP-TB(99.48),而对照组的平均等级明显较低(40.16)。截止点为25 U / L;敏感性,特异性,阳性预测值和阴性预测值分别为90.7%,100%,90.66%和100%。从数据可以得出结论,p = 0.037的性别智商分布与p = 0.142的痰液分级智商分布的平均等级差异不显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号